SEC Tracker
Get the app

NextCure NXTC

NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy

Form
8-K
Filed
Importance
Routine
  • Signs a material agreement (1.01)
  • Announces exit or restructuring costs (2.05)
  • Reports a change in control (5.01)
  • Reports an executive or board change (5.02)
  • Makes a Regulation FD disclosure (7.01)
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when NextCure files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Cellectar Biosciences CLRB public float $13M, Jun 30, 2025
  2. Synergy CHC SNYR public float $13M, Jun 30, 2025
  3. Cypherpunk Technologies CYPH public float $12M, Jun 30, 2025
  4. Earth Science Tech ETST public float $14M, Mar 31, 2026
  5. Cocrystal Pharma COCP public float $12M, Jun 30, 2025